US2009138988A1PendingUtilityA1
Modification of plant disease resistance
Est. expiryJul 21, 2027(~1 yrs left)· nominal 20-yr term from priority
C12N 15/8281C12N 9/1007C12N 9/1085
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides methods of increasing resistance to disease in a plant. Also provided are plant steroid biosynthesis enzyme coding sequences, including sequences for squalene synthase, constructs comprising these sequences, plants transformed therewith and methods of use thereof. Methods for producing a plant with increased disease resistance are also provided. In certain aspects of the invention, methods for producing plants transformed with the nucleic acids are provided, the transformed plants exhibiting improved disease resistance.
Claims
exact text as granted — not AI-modified1 . A method for increasing disease resistance in a plant comprising expressing in the plant a heterologous nucleic acid encoding squalene synthase or sterol methyltransferase.
2 . The method of claim 1 comprising expressing in the plant a nucleic acid encoding squalene synthase.
3 . The method of claim 1 , wherein the nucleic acid sequence is operably linked to a promoter functional in a plant cell and wherein the nucleic acid sequence is selected from the group consisting of:
(a) a nucleic acid sequence comprising SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5 or SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, or SEQ ID NO:11; (b) a nucleic acid sequence encoding the polypeptide of SEQ ID NO: 12, SEQ ID NO: 13, or SEQ ID NO: 14; (c) a nucleic acid sequence having at least 85% sequence identity to the nucleic acid sequence of (a) or (b); (d) a nucleic acid sequence complementary to the nucleic acid sequence of (a) or (b); and (e) a nucleic acid sequence that hybridizes to the sequence of (a) or (b) under conditions of 0.15 M NaCl at 70° C.
4 . The method of claim 3 , wherein the plant is a monocot.
5 . The method of claim 3 wherein the plant is a dicot.
6 . The method of claim 5 , wherein the plant is Arabidopsis thaliana or Nicotiana benthamiana.
7 . The method of claim 3 , wherein the promoter is inducible, organelle-specific, tissue-specific, pathogen-induced, cell-specific, developmentally-specific or constitutive.
8 . The method of claim 3 , wherein the construct comprises at least one additional sequence chosen from the group consisting of: a regulatory sequence, a selectable marker, a screenable marker, a secretable marker, a leader sequence, and a terminator.
9 . The method of claim 3 , wherein the construct is inherited from a parent plant of the plant.
10 . The method of claim 3 , wherein the plant is an R 0 transgenic plant.
11 . The method of claim 3 wherein resistance to P. syringae pv. glycinea or P. syringae pv. tomato is increased.
12 . A method of producing a transgenic plant having enhanced disease resistance comprising introducing into the plant a recombinant DNA construct comprising a promoter functional in plants operably linked to a nucleic acid molecule selected from the group consisting of:
(a) a nucleic acid sequence comprising the sequence of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5 or SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, or SEQ ID NO:11; (b) a nucleic acid sequence encoding the polypeptide of SEQ ID NO: 12, SEQ ID NO: 13, or SEQ ID NO: 14; (c) a nucleic acid sequence having at least 85% sequence identity to the nucleic acid sequence of (a) or (b); (d) a nucleic acid sequence complementary to a nucleic acid sequence of (a) or (b) (e) a nucleic acid sequence that hybridizes to the sequence of (a) or (b) under conditions of 0.15 M NaCl and 70° C.
13 . The method of claim 12 , wherein the plant is a monocot.
14 . The method of claim 12 wherein the plant is a dicot.
15 . The method of claim 14 , wherein the plant is Arabidopsis thaliana or Nicotiana benthamiana.
16 . The method of claim 12 , wherein the promoter is inducible, organelle-specific, tissue-specific, cell-specific, developmentally-specific or constitutive.
17 . The method of claim 12 , wherein the construct comprises at least one additional sequence chosen from the group consisting of: a regulatory sequence, a selectable marker, a screenable marker, a secretable marker, a leader sequence, and a terminator.
18 . The method of claim 12 , wherein the construct is inherited from a parent plant of the plant.
19 . The method of claim 12 , wherein the plant is an R 0 transgenic plant.
20 . The method of claim 12 wherein resistance to P. syringae pv. glycinea or P. syringae pv. tomato is increased.Join the waitlist — get patent alerts
Track US2009138988A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.